Jan 22 (Reuters) - Moderna does ‌not ​plan to ‌invest in new late-stage vaccine ​trials because of growing opposition to ‍immunizations from U.S. ​officials, CEO Stephane Bancel ​said ⁠in an interview ...
"Bloomberg Markets" follows the market moves across every global asset class and discusses the biggest issues for Wall Street ...
ORLANDO, FLORIDA / ACCESS Newswire / January 16, 2026 / RedChip Companies will air interviews with Alliance Entertainment ...